Oligonucleotides as research, diagnostic, and therapeutic agents.
about
mRNA display: diversity matters during in vitro selectionInhibition of tumorigenicity of the teratoma PC cell line by transfection with antisense cDNA for PC cell-derived growth factor (PCDGF, epithelin/granulin precursor)From oligonucleotide shapes to genomic SELEX: novel biological regulatory loopsNucleic acid aptamers: research tools in disease diagnostics and therapeuticsThrombin-aptamer recognition: a revealed ambiguityDesign, biological activity and NMR-solution structure of a DNA analogue of yeast tRNA(Phe) anticodon domainInterlocking structural motifs mediate molecular discrimination by a theophylline-binding RNAIdentification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targetingAptamers and the RNA world, past and presentAptamer-based multiplexed proteomic technology for biomarker discoveryEncoded self-assembling chemical libraries.Aptamers against prion proteins and prions.Interactions of Escherichia coli RNA with bacteriophage MS2 coat protein: genomic SELEXStaining of cell surface human CD4 with 2'-F-pyrimidine-containing RNA aptamers for flow cytometryMirror-image RNA that binds D-adenosine.Methylation potential associated with diet, genotype, protein, and metabolite levels in the Delta Obesity Vitamin StudyUsing in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligandsFrom SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assayGenetic associations with micronutrient levels identified in immune and gastrointestinal networks.Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44DNA enzymes.Aptamers as analytical reagents.Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment.Biocompatible artificial DNA linker that is read through by DNA polymerases and is functional in Escherichia coli.In vivo imaging with oligonucleotides for diagnosis and drug development.Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic AgentsRNA aptamers that functionally interact with green fluorescent protein and its derivatives.Regulatable aptamers in medicine: focus on antithrombotic strategies.High affinity ligands from in vitro selection: complex targets.Natural and unnatural answers to evolutionary questions.Aptamers for Targeted Drug DeliveryMultivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice.Creation of RNA molecules that recognize the oxidative lesion 7,8-dihydro-8-hydroxy-2'-deoxyguanosine (8-oxodG) in DNA.TFIIB aptamers inhibit transcription by perturbing PIC formation at distinct stages.In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor.High-affinity and specific recognition of human thyroid stimulating hormone (hTSH) by in vitro-selected 2'-amino-modified RNA.Potent 2'-amino-, and 2'-fluoro-2'-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor.In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia.DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice.Calcium-dependent oligonucleotide antagonists specific for L-selectin.
P2860
Q24610361-327B5AA8-AAE9-486A-BA6C-BA13D94CBB94Q24652242-8BC9ADDF-9FC9-4CC1-B7C7-4FD68F0F500DQ24671006-2DF9BEBA-CBC2-4F95-8345-86236047B1B9Q26824321-39034570-29CB-43FD-AC68-DA291FC284A5Q27670605-3A6F2B4B-D9A5-4871-815F-4F1165FC48CCQ27732234-9430193F-417F-466E-BEDC-D2CC88E024BDQ27741469-2C0067F4-3141-42BC-B646-D72B2DF230F0Q28475666-76DFF04A-823B-4D11-AB3D-544E2B3B80CCQ28731938-0F7682EB-41A0-468B-9768-13D053E506FCQ28744329-025E35B7-8A7D-4FFA-A75C-DB6BC8159790Q30760719-0CE47667-CA9E-4730-A8B9-D8847DC1DF65Q30860694-32C414D5-42FA-4C23-8072-1EA0EBB63967Q31818949-EF3DF710-2C43-413C-A644-CC447EC592CCQ32038821-8EC76CF0-A1E1-4E36-842F-7E746441A5DEQ32060741-7F98E9EC-ACEA-4B34-8587-80029C786492Q33632915-AE060AF5-8D84-41CB-B5DE-E590B3DA0AC0Q33657353-9324B90E-A3B8-4C93-87E7-81B1B98D2744Q34056289-192F3A4B-6D50-4F47-A752-56F7D6C64A35Q34212877-F6F14369-EB16-4A54-A7BC-852EAD4E9274Q34309819-490A9DDD-7E01-44CB-8F7C-82B2539660E1Q34424342-CAD1889D-8811-466E-9D72-D46738164210Q34635183-17224E00-00B0-4E50-9066-F9C327DAB707Q34700076-17CCDB88-9491-46DA-B907-32401BC6D41AQ35105285-B0F918E7-8B1E-4B39-A4BE-46CE4D6001BCQ35127223-D43228B4-A23E-476C-AF3D-242D63DD7DF7Q35309726-0F4AE143-1313-4F00-A584-1C4E2008CEC5Q35823691-5D05AF3C-E237-4A74-BBD4-9FFC9B025834Q35907032-92DD4B09-C064-467E-8387-F33CCE49AD81Q35974349-1B8AAA9C-3F48-45C3-8263-3318A0EAD98CQ36009667-4FA5BD5A-3273-4830-8161-7B2FD7931D9EQ36155891-F751DF38-4DB7-4403-929C-9A8CDF89F165Q36183600-346B9B63-D632-4B8A-AA3A-748A44639CA1Q36315476-F4E4E495-6463-44F8-87D8-473AE3978239Q36676498-E422F3FF-F4AB-4DC4-B780-7C0A57FC520FQ36729048-F2800AA1-0129-417B-8A4D-990E55FF3C70Q36820144-1600B3B8-B3DF-4077-AE54-CA7D13AF683EQ36846788-EB17F73F-8C32-4184-A3B4-0C44A8845799Q37355240-6D29E4D8-EBAE-4E35-B7F9-86361895B83BQ37362089-6EF83BE7-C982-46DE-9C90-41BFE085D062Q37560580-14F73ED9-9C66-450E-AE9E-86F50DA12E19
P2860
Oligonucleotides as research, diagnostic, and therapeutic agents.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Oligonucleotides as research, diagnostic, and therapeutic agents.
@en
type
label
Oligonucleotides as research, diagnostic, and therapeutic agents.
@en
prefLabel
Oligonucleotides as research, diagnostic, and therapeutic agents.
@en
P2860
P356
P1476
Oligonucleotides as research, diagnostic, and therapeutic agents.
@en
P2093
P2860
P304
13581-13584
P356
10.1074/JBC.270.23.13581
P407
P577
1995-06-01T00:00:00Z